+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Care Adsorption Solutions Market - Global Forecast to 2030- Product Image
Critical Care Adsorption Solutions Market - Global Forecast to 2030- Product Image
New

Critical Care Adsorption Solutions Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6078995
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Executive Summary: Navigating Critical Care Adsorption Solutions

Critical care adsorption technologies have emerged as vital tools for managing complex patient conditions where rapid toxin removal or molecular separation can mean the difference between recovery and deterioration. This report provides a concise exploration of how adsorption solutions-ranging from traditional activated charcoal to advanced polymer and resin systems-are reshaping critical care protocols. We examine the forces driving innovation, regulatory challenges and economic shifts, and the strategic segmentation that reveals untapped opportunities. By delivering a clear roadmap of market dynamics and competitive landscapes, this executive summary equips stakeholders with the insights needed to make informed decisions and accelerate adoption of best-in-class adsorption therapies.

Transformative Shifts in the Critical Care Adsorption Landscape

The adsorption landscape has undergone a remarkable transformation as material science breakthroughs and data-driven clinical practices converge. Innovations in graphene-enhanced activated charcoal, silicon carbide coatings and precision resin adsorbents are elevating performance benchmarks. Simultaneously, the integration of AI-powered analytics and remote monitoring is enabling real-time optimization of hemoperfusion protocols, reducing adverse events and improving patient outcomes. These shifts reflect a broader trend toward personalized therapies: molecular sieves tailored for specific toxin profiles and foam substrates engineered to modulate biocompatibility. As digital platforms provide deeper insights into adsorption kinetics and sorbent regeneration, care teams can iterate treatment plans with unprecedented agility. Ultimately, this confluence of advanced materials, intelligent monitoring and adaptive clinical workflows is redefining the standard of care in critical settings.

Cumulative Impact of United States Tariffs 2025 on Cost and Supply Chains

In 2025, new United States tariffs targeting imported polymers and specialty sorbent materials are exerting significant pressure on cost structures across the critical care adsorption supply chain. Manufacturers reliant on granular and powdered activated charcoal sourced from overseas are experiencing margin compression, while producers of macropore and micropore resins face increased costs for raw precursors. The tariff escalation has also impacted thermally treated high-density and low-density sorbents, driving up manufacturing overheads. To mitigate these effects, several key players have accelerated localization of raw material processing and forged strategic alliances with domestic chemical producers. At the same time, price sensitivity among hospital procurement teams has intensified, prompting suppliers to explore value-based contracting and risk-sharing models. As a result, the cumulative impact of 2025 tariffs is catalyzing supply chain resilience initiatives and reshaping competitive positioning in the critical care adsorption sector.

Key Segmentation Insights That Drive Strategic Focus

A nuanced segmentation framework reveals where growth opportunities and competitive pressures intersect across five critical dimensions. Based on product, the market comprises activated charcoal-examined through granular and powdered formats-polyvinyl alcohol foam available in closed-cell and open-cell variants, resin adsorbents differentiated into macropore and micropore formulations, and thermally treated sorbents produced in high-density and low-density grades. Application-oriented analysis covers anion exchange processes focused on chromate and nitrate removal, hemoperfusion techniques targeting autoimmune diseases such as rheumatoid arthritis and systemic lupus alongside poisoning management for heavy metals and overdose cases including opioids and sedatives, and molecular sieves primarily utilizing zeolites. End-user segmentation spans government and military facilities including defense research centers and field hospitals; hospitals within private and public healthcare systems; research laboratories encompassing academic and corporate R&D; and specialty clinics such as critical care centers and dialysis units. From a technology standpoint, advanced materials like graphene-based coatings and silicon carbide layers, digital monitoring solutions featuring AI analytics and remote sensors, and integrated miniaturized or modular systems are reshaping value propositions. Treatment type classification distinguishes acute care treatments for conditions like acute respiratory distress syndrome and sepsis from chronic care interventions addressing chronic kidney disease.

Key Regional Insights Highlighting Adoption and Regulatory Trends

Regional dynamics underscore distinct adoption patterns and regulatory environments across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, robust investment in digital health infrastructure and established reimbursement frameworks are accelerating uptake of AI-powered hemoperfusion systems. Meanwhile, EMEA’s diverse regulatory landscape and emphasis on defense-grade bioprocessing in government and military facilities present opportunities for advanced materials and modular therapy platforms. In Asia-Pacific, rapid expansion of specialty clinics and increasing incidence of sepsis and renal disorders are fueling demand for cost-effective resin adsorbents and localized manufacturing of activated charcoal to circumvent import tariffs. Collaboration between local research institutions and global technology providers is strengthening advanced material pipelines, while reimbursement reforms in key markets are laying the groundwork for broader access to integrated adsorption solutions.

Key Company Insights Shaping Market Leadership

Global competition in critical care adsorption is led by a consortium of specialized medical device and materials companies. Advanced Sterilization Products has leveraged its expertise in sterilization to introduce biocompatible sorbent cartridges. Baxter International Inc. and its Gambro subsidiary are expanding hemoperfusion portfolios that address autoimmune indications and poisoning management. BioInteractions Ltd. focuses on polymer sorbents with tailored pore structures, while CytoSorbents Corporation leads in cytokine adsorption therapies. EFFERTECH s.r.l brings precision engineering to modular miniaturized systems, and ExThera Medical Corporation offers integrated cartridges for sepsis management. Fresenius Medical Care continues to dominate renal adsorption through its dialysis-compatible sorbents, supported by Jafron Biomedical Co., Ltd., which excels in hemoperfusion columns for heavy metal and overdose treatment. Medasorb Technologies Corporation is advancing resin adsorbent customization, Nikkiso Co., Ltd. drives digital monitoring integration, Spectral Medical Inc. pioneers AI analytics in critical care, Terumo Corporation delivers advanced materials like silicon carbide coatings, and Toray Industries, Inc. innovates with graphene-based solutions.

Actionable Recommendations for Critical Care Adsorption Market Leaders

Industry leaders should prioritize investment in localized supply chains to mitigate tariff-driven cost volatility. Establishing joint ventures with domestic chemical producers can secure access to activated charcoal and resin precursors at competitive rates. Concurrently, companies must accelerate development of AI-powered monitoring solutions that integrate seamlessly with existing critical care workflows, enabling real-time performance analytics and predictive maintenance of adsorption systems. Collaborations with academic and corporate R&D laboratories will expedite advancement of next-generation sorbents, including graphene-enhanced substrates and hybrid foam composites. Leaders should also pilot value-based contracting models with major healthcare providers, aligning commercial outcomes with clinical efficacy to foster long-term adoption. By embracing modular system architectures, firms can scale production rapidly and customize solutions for diverse end-user segments, from field hospitals to specialty clinics. A strategic focus on these initiatives will fortify market positions and unlock sustainable growth pathways.

Conclusion: Positioning for the Next Wave of Critical Care Adsorption Advances

This executive summary has illuminated the evolving landscape of critical care adsorption: from material innovations and digital integration to tariff-induced supply chain realignments and strategic segmentation across products, applications, end users, technologies and treatments. By synthesizing regional nuances and competitive insights, we provide a clear framework for decision-makers to navigate emerging challenges and capitalize on high-impact opportunities. Success will hinge on agile strategies that balance cost optimization with clinical performance, as well as collaborations that accelerate R&D and streamline commercialization. As the sector advances, continuous monitoring of regulatory shifts and technological breakthroughs will remain paramount. Armed with these insights and recommendations, stakeholders are well-positioned to drive the next wave of transformative outcomes in critical care adsorption.

Market Segmentation & Coverage

This research report categorizes the Critical Care Adsorption Solutions Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Activated Charcoal
    • Granular Activated Charcoal
    • Powdered Activated Charcoal
  • Polyvinyl Alcohol Foam
    • Closed-Cell Foam
    • Open-Cell Foam
  • Resin Adsorbents
    • Macropore Resin
    • Micropore Resin
  • Thermally Treated Sorbents
    • Thermal-Treated High-Density
    • Thermal-Treated Low-Density
  • Anion Exchange
    • Chromate Removal
    • Nitrate Removal
  • Hemoperfusion
    • Autoimmune Diseases
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
    • Poisoning Management
      • Heavy Metal Poisoning
      • Overdose
        • Opioid Overdose
        • Sedative Overdose
  • Molecular Sieves
    • Zeolites
  • Government & Military
    • Defense Research Facilities
    • Field Hospitals
  • Hospitals
    • Private Institutions
    • Public Healthcare System
  • Research Laboratories
    • Academic Research
    • Corporate R&D
  • Specialty Clinics
    • Critical Care Centers
    • Dialysis Clinics
  • Advanced Materials
    • Graphene-Based Technologies
    • Silicon Carbide Coatings
  • Digital Monitoring
    • AI-Powered Analytics
    • Remote Monitoring
  • Integrated Systems
    • Miniaturized Systems
    • Modular Systems
  • Acute Care Treatments
    • Acute Respiratory Distress Syndrome
    • Sepsis Management
  • Chronic Care Treatments
    • Chronic Kidney Disease

This research report categorizes the Critical Care Adsorption Solutions Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Critical Care Adsorption Solutions Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advanced Sterilization Products (ASP Medical)
  • Baxter International Inc.
  • BioInteractions Ltd.
  • CytoSorbents Corporation
  • EFFERTECH s.r.l
  • ExThera Medical Corporation
  • Fresenius Medical Care
  • Gambro (Part of Baxter International Inc.)
  • Jafron Biomedical Co., Ltd.
  • Medasorb Technologies Corporation
  • Nikkiso Co., Ltd.
  • Spectral Medical Inc.
  • Terumo Corporation
  • Toray Industries, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Critical Care Adsorption Solutions Market, by Product
8.1. Introduction
8.2. Activated Charcoal
8.2.1. Granular Activated Charcoal
8.2.2. Powdered Activated Charcoal
8.3. Polyvinyl Alcohol Foam
8.3.1. Closed-Cell Foam
8.3.2. Open-Cell Foam
8.4. Resin Adsorbents
8.4.1. Macropore Resin
8.4.2. Micropore Resin
8.5. Thermally Treated Sorbents
8.5.1. Thermal-Treated High-Density
8.5.2. Thermal-Treated Low-Density
9. Critical Care Adsorption Solutions Market, by Application
9.1. Introduction
9.2. Anion Exchange
9.2.1. Chromate Removal
9.2.2. Nitrate Removal
9.3. Hemoperfusion
9.3.1. Autoimmune Diseases
9.3.1.1. Rheumatoid Arthritis
9.3.1.2. Systemic Lupus Erythematosus
9.3.2. Poisoning Management
9.3.2.1. Heavy Metal Poisoning
9.3.2.2. Overdose
9.3.2.2.1. Opioid Overdose
9.3.2.2.2. Sedative Overdose
9.4. Molecular Sieves
9.4.1. Zeolites
10. Critical Care Adsorption Solutions Market, by End-User
10.1. Introduction
10.2. Government & Military
10.2.1. Defense Research Facilities
10.2.2. Field Hospitals
10.3. Hospitals
10.3.1. Private Institutions
10.3.2. Public Healthcare System
10.4. Research Laboratories
10.4.1. Academic Research
10.4.2. Corporate R&D
10.5. Specialty Clinics
10.5.1. Critical Care Centers
10.5.2. Dialysis Clinics
11. Critical Care Adsorption Solutions Market, by Technology
11.1. Introduction
11.2. Advanced Materials
11.2.1. Graphene-Based Technologies
11.2.2. Silicon Carbide Coatings
11.3. Digital Monitoring
11.3.1. AI-Powered Analytics
11.3.2. Remote Monitoring
11.4. Integrated Systems
11.4.1. Miniaturized Systems
11.4.2. Modular Systems
12. Critical Care Adsorption Solutions Market, by Treatment Types
12.1. Introduction
12.2. Acute Care Treatments
12.2.1. Acute Respiratory Distress Syndrome
12.2.2. Sepsis Management
12.3. Chronic Care Treatments
12.3.1. Chronic Kidney Disease
13. Americas Critical Care Adsorption Solutions Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Critical Care Adsorption Solutions Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Critical Care Adsorption Solutions Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Sterilization Products (ASP Medical)
16.3.2. Baxter International Inc.
16.3.3. BioInteractions Ltd.
16.3.4. CytoSorbents Corporation
16.3.5. EFFERTECH s.r.l
16.3.6. ExThera Medical Corporation
16.3.7. Fresenius Medical Care
16.3.8. Gambro (Part of Baxter International Inc.)
16.3.9. Jafron Biomedical Co., Ltd.
16.3.10. Medasorb Technologies Corporation
16.3.11. Nikkiso Co., Ltd.
16.3.12. Spectral Medical Inc.
16.3.13. Terumo Corporation
16.3.14. Toray Industries, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET MULTI-CURRENCY
FIGURE 2. CRITICAL CARE ADSORPTION SOLUTIONS MARKET MULTI-LANGUAGE
FIGURE 3. CRITICAL CARE ADSORPTION SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CRITICAL CARE ADSORPTION SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRANULAR ACTIVATED CHARCOAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POWDERED ACTIVATED CHARCOAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLOSED-CELL FOAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OPEN-CELL FOAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MACROPORE RESIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MICROPORE RESIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMAL-TREATED HIGH-DENSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMAL-TREATED LOW-DENSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHROMATE REMOVAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NITRATE REMOVAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEAVY METAL POISONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OPIOID OVERDOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEDATIVE OVERDOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DEFENSE RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY FIELD HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRIVATE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PUBLIC HEALTHCARE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CORPORATE R&D, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CRITICAL CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAPHENE-BASED TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SILICON CARBIDE COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AI-POWERED ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MINIATURIZED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 155. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 157. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 158. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 159. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 160. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 162. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 163. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 164. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 166. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 167. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 169. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 171. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 175. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 177. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 178. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 182. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 186. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 188. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 190. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 199. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 200. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OVERDOSE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MOLECULAR SIEVES, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GOVERNMENT & MILITARY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADVANCED MATERIALS, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DIGITAL MONITORING, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TREATMENT TYPES, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC CARE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 277. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CHARCOAL, 2018-2030 (USD MILLION)
TABLE 279. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYVINYL ALCOHOL FOAM, 2018-2030 (USD MILLION)
TABLE 280. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESIN ADSORBENTS, 2018-2030 (USD MILLION)
TABLE 281. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY THERMALLY TREATED SORBENTS, 2018-2030 (USD MILLION)
TABLE 282. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ANION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 284. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION, 2018-2030 (USD MILLION)
TABLE 285. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 286. CHINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POISONING MANAGEMENT, 2018-2030 (

Companies Mentioned

  • Advanced Sterilization Products (ASP Medical)
  • Baxter International Inc.
  • BioInteractions Ltd.
  • CytoSorbents Corporation
  • EFFERTECH s.r.l
  • ExThera Medical Corporation
  • Fresenius Medical Care
  • Gambro (Part of Baxter International Inc.)
  • Jafron Biomedical Co., Ltd.
  • Medasorb Technologies Corporation
  • Nikkiso Co., Ltd.
  • Spectral Medical Inc.
  • Terumo Corporation
  • Toray Industries, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Critical Care Equipment Market - Global Forecast to 2030 - Product Image

Critical Care Equipment Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Tele-intensive Care Unit Market - Global Forecast to 2030 - Product Image

Tele-intensive Care Unit Market - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
U.S. Urgent Care Centers Market Size, Share & Trends Analysis Report by Application (Acute Respiratory Infection, Injuries, Joint/Soft Tissue Issues), Ownership (Hospital, Corporation, Physicians) with Growth Forecasts, 2025-2030 - Product Image

U.S. Urgent Care Centers Market Size, Share & Trends Analysis Report by Application (Acute Respiratory Infection, Injuries, Joint/Soft Tissue Issues), Ownership (Hospital, Corporation, Physicians) with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • United States
From
Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Critical Care Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Critical Care Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.